Noninvasive Early Detection and Recurrence Monitoring for Non-Muscle-Invasive Bladder Cancer via Urine Tumor DNA: A Prospective Clinical Study.

MedComm (2020) · 2026 · PMC12805463 · PMID 41550467

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

showed a trendp = 0.071so close (0.05 < p ≤ 0.1)

Notably, patients with negative preoperative utLIFE‐UC results showed a trend toward better prognosis compared to positive cases ( p = 0.071) (Figure 2E ). 2.3 Utility of utLIFE‐UC to Identify Residual Tumor After Initial TURBT Twenty patients successfully underwent utDNA examination prior to Re‐TURBT to investigate the value of utLIFE‐UC in detecting residual tumors following initial TURBT.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.